Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 2
1987 1
1993 1
1998 1
2002 1
2007 1
2009 1
2010 2
2011 2
2012 4
2013 5
2014 8
2015 3
2016 2
2017 4
2018 2
2019 3
2020 2
2021 3
2022 4
2023 5
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors.
Pecci F, Nakazawa S, Ricciuti B, Harada G, Lee JK, Alessi JV, Barrichello A, Vaz VR, Lamberti G, Di Federico A, Gandhi MM, Gazgalis D, Feng WW, Jiang J, Baldacci S, Locquet MA, Gottlieb FH, Chen MF, Lee E, Haradon D, Smokovich A, Voligny E, Nguyen T, Goel VK, Zimmerman Z, Atwal S, Wang X, Bahcall M, Heist RS, Iqbal S, Gandhi N, Elliott A, Vanderwalde AM, Ma PC, Halmos B, Liu SV, Che J, Schrock AB, Drilon A, Jänne PA, Awad MM. Pecci F, et al. Among authors: atwal s. Cancer Discov. 2024 Aug 2;14(8):1440-1456. doi: 10.1158/2159-8290.CD-23-1217. Cancer Discov. 2024. PMID: 38564707 Free PMC article.
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia.
Lawson H, Holt-Martyn JP, Dembitz V, Kabayama Y, Wang LM, Bellani A, Atwal S, Saffoon N, Durko J, van de Lagemaat LN, De Pace AL, Tumber A, Corner T, Salah E, Arndt C, Brewitz L, Bowen M, Dubusse L, George D, Allen L, Guitart AV, Fung TK, So CWE, Schwaller J, Gallipoli P, O'Carroll D, Schofield CJ, Kranc KR. Lawson H, et al. Among authors: atwal s. Nat Cancer. 2024 Jun;5(6):916-937. doi: 10.1038/s43018-024-00761-w. Epub 2024 Apr 18. Nat Cancer. 2024. PMID: 38637657 Free PMC article.
Pulmonary Aspergillosis: What CT can Offer Before it is too Late!
Prasad A, Agarwal K, Deepak D, Atwal SS. Prasad A, et al. Among authors: atwal ss. J Clin Diagn Res. 2016 Apr;10(4):TE01-5. doi: 10.7860/JCDR/2016/17141.7684. Epub 2016 Apr 1. J Clin Diagn Res. 2016. PMID: 27190919 Free PMC article. Review.
Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma.
Tam CS, Opat S, Simpson D, Cull G, Munoz J, Phillips TJ, Kim WS, Rule S, Atwal SK, Wei R, Novotny W, Huang J, Wang M, Trotman J. Tam CS, et al. Among authors: atwal sk. Blood Adv. 2021 Jun 22;5(12):2577-2585. doi: 10.1182/bloodadvances.2020004074. Blood Adv. 2021. PMID: 34152395 Free PMC article. Clinical Trial.
60 results